Petros Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2023 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Petros Pharmaceuticals, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q3 2024.
Petros Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024		$0	-$30.8K	-100%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-13
Q2 2024		$16.8K	-$26.5K	-61.1%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024		$180K	+$50K	+38.4%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q3 2023		$30.8K			Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-13
Q2 2023		$43.3K			Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023		$130K			Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.